Trial NCT01632566

View at ClinicalTrials.gov 
Org. Study IDs: 14284
Secondary IDs: I5W-EW-LBCB

Last trial update was posted on 2019-06-27

MeSH Interventions

Celecoxib LY3031207 Simvastatin

MeSH Conditions


Other Conditions

Healthy Volunteers

Stopping Reasons

Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some participants.

Limitations And Caveats

Lilly voluntarily discontinued dosing of LY3031207 for all participants in LBCB because of early discontinuation criteria being met. Data for some endpoints (including blood pressure and Japanese comparison) were incomplete for the planned analyses.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID